NEW YORK (GenomeWeb News) — GenOway will supply “a leading” but undisclosed US pharmaceutical company with its genetically modified mouse lines in exchange for up to $2 million, the firm said yesterday.
 
GenOway makes a line of genetically modified mouse and rat lines, and uses knowledge in transgenic technologies including pronuclear microinjection, knock-out, knock-in, knock-down, point mutation, in vivo drug screening, drug efficacy, and safety testing.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.